Cell and Gene Therapy Containment
Overcoming Challenges in Cell and Gene Therapy Containment.
List view / Grid view
Overcoming Challenges in Cell and Gene Therapy Containment.
Understanding and Applying the Updated FDA Guidance: Inspection of Injectable Products for Visible Particulates.
With a growing pipeline of biologics, increase in vaccine production, and small batch sizes targeting small patient populations, there’s increasing demand for advanced manufacturing tech.
Drug-device combination products offer advantages for patients but are complex and challenging to develop. Establish a holistic approach to DDCP development and assess and manage risk throughout the process.
24 October 2024 | By
Whitepaper - Delivering Market Success for Pharma Partners from Concept to Patient
Selecting container closure components with confidence:A data-driven approach to Container Closure Integrity.
CPHI Milan takes place in October, covering a wide range of topics from packaging and drug delivery to integrated pharma.
This feature partnership covers how pharma companies can ensure they are end-to-end compliant with Annex 1 for their primary packaging via a robust CCS.
European Pharmaceutical Review Issue 4 includes articles on regulation, bioproduction, environmental monitoring, packaging and drug delivery.
Simplify your move from a vial to a prefilled syringe – lifecycle planning for containment and delivery of biologics drug products
How you can cut through complexity, gain speed and get your drug to the patient as soon as possible.
With complex processes and stringent regulatory requirements, the path to developing a combination product can be uncertain and challenging
23 August 2024 | By
This blog is a summary of the key changes of relevance to primary packaging components
8 August 2024 | By
A leading provider of innovative, high-quality injectable solutions and services, and a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of lifesaving and life-enhancing medicines for patients.
30 July 2024 | By West Pharmaceutical Services
This webinar explores the key considerations in component selection when moving from a vial to a prefilled syringe during biologic drug development.